Aortic regurgitation

New England Journal of Medicine

Volumn 351, Issue 15, 2004, Pages

  Enriquez Sarano, Maurice ^a   Tajik, A Jamil ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE; VASODILATOR AGENT;

ADULT; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; BLOOD PRESSURE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONSERVATIVE TREATMENT; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FATIGUE; FEMALE; HEART MURMUR; HEART SOUND; HUMAN; IMAGE ANALYSIS; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSE RATE; SYMPTOM; AORTA; AORTA VALVE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VALVE REPLACEMENT; MIDDLE AGED; POSTOPERATIVE COMPLICATION; REVIEW;

AORTA; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES; VASODILATOR AGENTS;

EID: 19544384887     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp030912     Document Type: Article

References (43)

1. Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: Saunders, 1997.
2. Singh J, Evans J, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation. Am J Cardiol 1999;83:897-902. [Erratum, Am J Cardiol 1999;84:1143.]
3. Singh J, Evans J, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation. Am J Cardiol 1999;83:897-902. [Erratum, Am J Cardiol 1999;84:1143.]
4. Lebowitz NE, Bella JN, Roman MJ, et al. Prevalence and correlates of aortic regurgitation in American Indians: the Strong Heart Study. J Am Coll Cardiol 2000;36:461-7.
5. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol 1997;30;746-52.
6. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice: a long-term follow-up study. Circulation 1999;99:1851-7.
7. Bonow RO, Lakatos E, Maron BJ, Epstein SE. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation 1991;84:1625-35.
8. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Surgery for aortic regurgitation in women: contrasting indications and outcomes compared with men. Circulation 1996;94:2472-8.
9. Darles RR, Goldstein LJ, Coady MA, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg 2002;73:17-28.
10. Coady MA, Rizzo JA, Hammond GL, et al. What is the appropriate size criterion for resection of thoracic aortic aneurysms? J Thorac Cardiovasc Surg 1997;113:476-91.
11. Borer JS, Hochreiter C, Herrold EM, et al. Prediction of indication for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 1998;97:525-34.
12. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16:777-802.
13. Desjardins VA, Enriquez-Sarano M, Tajik AJ, Bailey KR, Seward JB. Intensity of murmurs correlates with severity of valvalar regurgitation. Am J Med 1996;100:149-56.
14. Tribouilloy CM, Enriquez-Sarano M, Mohty D, et al. Pathophysiologic determinants of third heart sounds: a prospective clinical and Doppler echocardiographic study. Am J Med 2001;111:96-102.
15. Tribouilloy CM, Enriquez-Sarano M, Fett SL, Bailey KR, Seward JB, Tajik AJ. Application of the proximal flow convergence method to calculate the effective regurgitant orifice area in aortic regurgitation. J Am Coll Cardiol 1998;32:1032-9.
16. Enriquez-Sarano M, Seward JB, Bailey KR, Tajik AJ. Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol 1994;23:443-51.
17. Reimold SC, Ganz P, Bittl JA, et al. Effective aortic regurgitant orifice area: description of a method based on the conservation of mass. J Am Coll Cardiol 1991;18:761-8.
18. Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Seward JB, Tajik AJ. Assessment of severity of aortic regurgitation using the width of the vena contracta: a clinical color Doppler imaging study. Circulation 2000; 102:558-64.
19. Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses. Curr Probl Cardiol 2000;25:73-154.
20. Tarasoutchi F, Grinberg M, Spina GS, et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol 2003; 41:1316-24.
21. Bonow R, Carabello B, DeLeon AC Jr, et al. Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-84.
22. Acar J, Luxereau P, Ducimetiere P, Cadilhac M, Jallut H, Vahanian A. Prognosis of surgically treated chronic aortic valve disease: predictive indicators of early postoperative risk and long-term survival based on 439 cases. J Thorac Cardiovasc Surg 1981; 82:114-26.
23. Bonow RO, Picone AL, McIntosh CL, et al. Survival and functional results after valve replacement for aortic regurgitation from 1976 to 1983: impact of preoperative left ventricular function. Circulation 1985;72: 1244-56.
24. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Aortic regurgitation complicated by extreme left ventricular dilatation: long-term outcome after surgical correction. J Am Coll Cardiol 1996; 27:670-7.
25. Iung B, Gohlke-Barwolf C, Tornos P, et al. Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 2002;23:1253-66.
26. Chaliki HP, Mohty D, Avierinos JF, et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 2002;106:2687-93.
27. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 1984;3:916-23.
28. Bonow RO, Dodd JT, Maron BJ, et al. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation 1988;78:1108-20.
29. Edwards FH, Peterson ED, Coombs LP, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001;37:885-92.
30. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346: 1128-37.
31. Gott VL, Cameron DE, Alejo DE, et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann Thorac Surg 2002;73:438-43.
32. Tornos MP, Permanyer-Miralda G, Evangelista A, et al. Clinical evaluation of a prospective protocol for the timing of surgery in chronic aortic regurgitation. Am Heart J 1990;120:649-57.
33. Levine H, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996;28: 1083-91.
34. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 1994;24: 1046-53.
35. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994;331:689-94.
36. Scognamiglio R, Fasoli G, Ponchia A, Dalla-Volta S. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990;16:424-9.
37. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994;330:1335-41.
38. American Heart Association. Wallet card page. (Accessed September 13, 2004, at http: //www.americanheart.org/downloadable/heart/ 1023826501754walletcard.pdf.)
39. Reimold SC, Orav EJ, Come PC, Caguioa ES, Lee RT. Progressive enlargement of the regurgitant orifice in patients with chronic aortic regurgitation. J Am Soc Echocardiogr 1998;11:259-65.
40. Boucher CA, Wilson RA, Kanarek DJ, et al. Exercise testing in asymptomatic or minimally symptomatic aortic regurgitation: relationship of left ventricular ejection fraction to left ventricular filling pressure during exercise. Circulation 1993;67:1091-100.
41. Gillinov AM, Blackstone EH, White J, et al. Durability of combined aortic and mitral valve repair. Ann Thorac Surg 2001;72:20-7.
42. Kouchoukos NT. Aortic allografts and pulmonary autografts for replacement of the aortic valve and aortic root. Ann Thorac Surg 1999;67:1846-8.
43. Acar J, Iung B, Boissel JP, et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996;94:2107-12.